You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

CLINICAL TRIALS PROFILE FOR ASENAPINE MALEATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ASENAPINE MALEATE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01948024 ↗	Bio-equivalence Study Between SAPHRIS and Asenapine	Completed	bioRASI, LLC	Phase 1	2013-07-01	This is a Multiple-dose, steady state, three-way reference-replicated crossover study. The purpose of this Study is to determine the bio-equivalence between SAPHRIS and Asenapine 10mg sublingual tablets.
NCT01948024 ↗	Bio-equivalence Study Between SAPHRIS and Asenapine	Completed	Sun Pharmaceutical Industries Limited	Phase 1	2013-07-01	This is a Multiple-dose, steady state, three-way reference-replicated crossover study. The purpose of this Study is to determine the bio-equivalence between SAPHRIS and Asenapine 10mg sublingual tablets.
NCT02072954 ↗	Bioequivalence Fasting Study in Patients	Completed	Accutest Research Laboratories (I) Pvt. Ltd.	Phase 2/Phase 3	2013-11-01	To compare and evaluate the oral bioavailability of Asenapine Sublingual Tablets, 10 mg manufactured by AMNEAL PHARMACEUTICALS, USA with SAPHRIS® (asenapine) sublingual tablets, 10 mg.
NCT02072954 ↗	Bioequivalence Fasting Study in Patients	Completed	Amneal Pharmaceuticals, LLC	Phase 2/Phase 3	2013-11-01	To compare and evaluate the oral bioavailability of Asenapine Sublingual Tablets, 10 mg manufactured by AMNEAL PHARMACEUTICALS, USA with SAPHRIS® (asenapine) sublingual tablets, 10 mg.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ASENAPINE MALEATE

Condition Name

Chart
Table

Condition Name for ASENAPINE MALEATE
Intervention	Trials
Schizophrenia	2
Bipolar Disorder	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ASENAPINE MALEATE
Intervention	Trials
Schizophrenia	2
Bipolar Disorder	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ASENAPINE MALEATE

Trials by Country

Map
Table

Trials by Country for ASENAPINE MALEATE
Location	Trials
United States	5
India	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ASENAPINE MALEATE
Location	Trials
North Carolina	1
Georgia	1
Florida	1
California	1
Arkansas	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ASENAPINE MALEATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ASENAPINE MALEATE
Clinical Trial Phase	Trials
Phase 2/Phase 3	1
Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ASENAPINE MALEATE
Clinical Trial Phase	Trials
Completed	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ASENAPINE MALEATE

Sponsor Name

Chart
Table

Sponsor Name for ASENAPINE MALEATE
Sponsor	Trials
bioRASI, LLC	2
Sun Pharmaceutical Industries Limited	2
Accutest Research Laboratories (I) Pvt. Ltd.	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ASENAPINE MALEATE
Sponsor	Trials
Industry	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.